[1. WHO Regional Committee for Europe, Action plan for the health sector response to viral hepatitis in the WHO European Region, WHO Regional Office for Europe, UN City, Marmorvej 51, DK-2100 Copenhagen Ø, Denmark, 2017, viii + 44 pages.]Search in Google Scholar
[2. IARC Working Group, HEPATITIS B VIRUS, International Agency for Research on Cancer, IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. 150 cours Albert Thomas, 69372 Lyon Cedex 08, France, 2012;100(Pt B):1-441.]Search in Google Scholar
[3. Lampertico P, Agarwal K, Berg T, Buti M, Janssen HLA, Papatheodoridis G, et al. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017 Aug;67(2):370-98. DOI: 10.1016/j.jhep.2017.03.02110.1016/j.jhep.2017.03.02128427875]Search in Google Scholar
[4. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394-424. DOI: 10.3322/caac.2149210.3322/caac.2149230207593]Search in Google Scholar
[5. Popovici O, Radu R, Romaniuc A, Azoicăi D. A sero-prevalence study for hepatitis B virus markers of infection in pregnant women in Romania: results and opportunities for prevention. J Gastrointestin Liver Dis. 2018 Jun;27(2):133-7. DOI: 10.15403/jgld.2014.1121.272. hpb10.15403/jgld.2014.1121.272]Search in Google Scholar
[6. Popovici O, Molnar GB, Popovici F, Janţă D, Pistol A, Azoicăi D. A Seroprevalence Study of Hepatitis B and C Virus Infections in a Hospitalized Population in Romania, an Opportunity for a Better National Prevention and Control Strategy. J Gastrointestin Liver Dis. 2016 Mar;25(1):25-32. DOI: 10.15403/jgld.2014.1121.251. hbc10.15403/jgld.2014.1121.251]Search in Google Scholar
[7. Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, et al. Update on Prevention, Diagnosis, and Treatment of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance. Clin Liver Dis (Hoboken). 2018 Aug 22;12(1):33-4. DOI: 10.1002/cld.72810.1002/cld.728638589930988907]Search in Google Scholar
[8. Ursu RG, Luca CM, Luca AS, Toader E, Simion L, Iancu LS. Laboratory diagnosis for optimize therapy of B hepatitis virus infection by using biochemical and molecular biology methods. Rev. Chim. (Bucharest), 2016; 67(12): 2614-261.]Search in Google Scholar
[9. Luca AS, Luca MC, Ursu RG, Iancu LS. The Study of VHB genotypes in a population - a pilot study. Rev. Chim. (Bucharest), 2016; 67(3): 500-2.]Search in Google Scholar
[10. Constantinescu I, Nedelcu F, Toader MA, Daniela V. Clinical and therapeutical importance of HBV genotyping in Romania. J Med Life. 2008 Apr-Jun;1(2):165-73.]Search in Google Scholar
[11. Constantinescu I, Dinu AA, Boscaiu V, Niculescu M. Hepatitis B virus core promoter mutations in patients with chronic hepatitis B and hepatocellular carcinoma in bucharest, Romania. Hepat Mon. 2014 Oct 20;14(10):e22072. DOI: 10.5812/hepatmon.2207210.5812/hepatmon.22072425096625477976]Search in Google Scholar
[12. Kmet Lunaček N, Poljak M, Matičič M. Distribution of hepatitis B virus genotypes in Europe and clinical implications: a review. Acta Dermatovenerol Alp Pannonica Adriat. 2018 Sep;27(3):141-6. DOI: 10.15570/actaapa.2018.2810.15570/actaapa.2018.28]Search in Google Scholar
[13. Toy M, Veldhuijzen IK, Mostert MC, de Man RA, Richardus JH. Transmission routes of hepatitis B virus infection in chronic hepatitis B patients in The Netherlands. J Med Virol. 2008 Mar;80(3):399-404. DOI: 10.1002/jmv.2109810.1002/jmv.2109818205235]Search in Google Scholar
[14. Moussa S, Brah S, Parola P, Gerolami R, Gamerre M, Boubli L, et al. Epidemiological, clinical, virological features of hepatitis B newly diagnosed in 2011 in Marseille University hospitals, southeastern France. J Med Virol. 2016 May;88(5):828-36. DOI: 10.1002/jmv.2439810.1002/jmv.2439826439319]Search in Google Scholar
[15. Ghany MG, Perrillo R, Li R, Belle SH, Janssen HL, Terrault NA et al. Characteristics of adults in the hepatitis B research network in North America reflect their country of origin and hepatitis B virus genotype. Clin Gastroenterol Hepatol. 2015 Jan;13(1):183-92.]Search in Google Scholar
[16. Lin CL, Kao JH. Natural history of acute and chronic hepatitis B: The role of HBV genotypes and mutants. Best Pract Res Clin Gastroenterol. 2017 Jun;31(3):249-55. DOI: 10.1016/j.bpg.2017.04.01010.1016/j.bpg.2017.04.01028774406]Search in Google Scholar
[17. Pourkarim MR, Amini-Bavil-Olyaee S, Kurbanov F, Van Ranst M, Tacke F. Molecular identification of hepatitis B virus genotypes/subgenotypes: revised classification hurdles and updated resolutions. World J Gastroenterol. 2014 Jun 21;20(23):7152-68. DOI: 10.3748/wjg.v20.i23.715210.3748/wjg.v20.i23.7152406406124966586]Search in Google Scholar
[18. Rajoriya N, Combet C, Zoulim F, Janssen HLA. How viral genetic variants and genotypes influence disease and treatment outcome of chronic hepatitis B. Time for an individualised approach? J Hepatol. 2017 Dec;67(6):1281-97. DOI: 10.1016/j.jhep.2017.07.01110.1016/j.jhep.2017.07.01128736138]Search in Google Scholar
[19. Sunbul M. Hepatitis B virus genotypes: global distribution and clinical importance. World J Gastroenterol. 2014 May 14;20(18):5427-34. DOI: 10.3748/wjg.v20. i18.5427]Search in Google Scholar
[20. Velkov S, Ott JJ, Protzer U, Michler T. The Global Hepatitis B Virus Genotype Distribution Approximated from Available Genotyping Data. Genes (Basel). 2018 Oct 15;9(10). DOI: 10.3390/genes910049510.3390/genes9100495621029130326600]Search in Google Scholar
[21. Lampe E, Mello FCA, do Espírito-Santo MP, Oliveira CMC, Bertolini DA, Gonçales NSL, et al. Nationwide overview of the distribution of hepatitis B virus genotypes in Brazil: a 1000-sample multicentre study. J Gen Virol. 2017 Jun;98(6):1389-98. DOI: 10.1099/jgv.0.00078910.1099/jgv.0.000789596289628631602]Search in Google Scholar
[22. Marciano S, Galdame OA, Gadano AC. HBV genotype F: natural history and treatment. Antivir Ther. 2013;18(3 Pt B):485-8. DOI: 10.3851/IMP260410.3851/IMP260423792712]Search in Google Scholar
[23. Hirzel C, Wandeler G, Owczarek M, Gorgievski-Hrisoho M, Dufour JF, Semmo N, et al. Molecular epidemiology of hepatitis B virus infection in Switzerland: a retrospective cohort study. BMC Infect Dis. 2015 Oct 30;15:483. DOI: 10.1186/s12879-015-1234-z10.1186/s12879-015-1234-z462834426518625]Search in Google Scholar
[24. Michitaka K, Hiraoka A, Imai Y, Utsunomiya H, Tatsukawa H, Shimizu Y, et al. Clinical features and hepatitis B virus (HBV) genotypes in pregnant women chronically infected with HBV. Intern Med. 2012;51(24):3317-22. DOI: 10.2169/internalmedicine.51.859610.2169/internalmedicine.51.859623257514]Search in Google Scholar
[25. Ding Y, Sheng Q, Ma L, Dou X. Chronic HBV infection among pregnant women and their infants in Shenyang, China. Virol J. 2013 Jan 7;10:17. DOI: 10.1186/1743-422X-10-1710.1186/1743-422X-10-17356801123294983]Search in Google Scholar
[26. Harder KM, Cowan S, Eriksen MB, Krarup HB, Christensen PB. Universal screening for hepatitis B among pregnant women led to 96% vaccination coverage among newborns of HBsAg positive mothers in Denmark. Vaccine. 2011 Nov 21;29(50):9303-7. DOI: 10.1016/j.vaccine.2011.10.02810.1016/j.vaccine.2011.10.02822019756]Search in Google Scholar
[27. Dervisevic S, Ijaz S, Chaudry S, Tedder RS. Non-A hepatitis B virus genotypes in antenatal clinics, United Kingdom. Emerg Infect Dis. 2007 Nov;13(11):1689-93. DOI: 10.3201/eid1311.07057810.3201/eid1311.070578337577818217552]Search in Google Scholar
[28. Sellier P, Maylin S, Amarsy R, Mazeron MC, Larrouy L, Haïm-Boukobza S, et al. Untreated highly viraemic pregnant women from Asia or sub-Saharan Africa often transmit hepatitis B virus despite serovaccination to newborns. Liver Int. 2015 Feb;35(2):409-16. DOI: 10.1111/liv.1256110.1111/liv.1256124698736]Search in Google Scholar
[29. Faleye TO, Adewumi MO, Ifeorah IM, Omoruyi EC, Bakarey SA, Akere A, et al. Detection of hepatitis B virus isolates with mutations associated with immune escape mutants among pregnant women in Ibadan, southwestern Nigeria. Springerplus. 2015 Feb 1;4:43. DOI: 10.1186/s40064-015-0813-110.1186/s40064-015-0813-1432014125674500]Search in Google Scholar
[30. Baclig MO, Reyes KG, Liles VR, Gopez-Cervantes J. Untypable genotype restriction patterns and surface gene variants of hepatitis B virus isolates. Int J Mol Epidemiol Genet. 2017 Jun 20;8(3):19-26.]Search in Google Scholar
[31. Pettersson JH, Myking S, Elshaug H, Bygdås KIE, Stene-Johansen K. Molecular epidemiology of hepatitis B virus infection in Norway. BMC Infect Dis. 2019 Mar 7;19(1):236. DOI: 10.1186/s12879-019-3868-810.1186/s12879-019-3868-8640726730845915]Search in Google Scholar
[32. Alidjinou EK, Bocket L, Pigot V, Lambert V, Hallaert C, Canva V, et al. Sanger sequencing versus INNO-Li-PA® HBV PreCore assay for routine detection of pre-core and basal core promoter mutations in hepatitis virus B chronically infected patients. Diagn Microbiol Infect Dis. 2018 Apr;90(4):277-279. DOI: 10.1016/j.diagmicrobio.2017.12.00610.1016/j.diagmicrobio.2017.12.00629310947]Search in Google Scholar
[33. Fung S, Kwan P, Fabri M, Horban A, Pelemis M, Hann HW et al. Randomized comparison of tenofovir disoproxil fumarate vs emtricitabine and tenofovir disoproxil fumarate in patients with lamivudine-resistant chronic hepatitis B. Gastroenterology. 2014 Apr;146(4):980-8. DOI: 10.1053/j.gastro.2013.12.02810.1053/j.gastro.2013.12.02824368224]Search in Google Scholar
[34. Chevaliez S, Dauvillier C, Dubernet F, Poveda JD, Laperche S, Hézode C, et al. The New Aptima HBV Quant Real-Time TMA Assay Accurately Quantifies Hepatitis B Virus DNA from Genotypes A to F. J Clin Microbiol. 2017 Apr;55(4):1211-9. DOI: 10.1128/JCM.02219-1610.1128/JCM.02219-16537784928202793]Search in Google Scholar